Saturday, February 24, 2018

Molecular Trojan horse delivers chemotherapeutic drug to cancer cells

Researchers have discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases. Until now, paclitaxel has only been used to target rapidly dividing cancer cells. The team was successful in getting the drug to piggyback on 123B9, an agent they devised to target an oncogene called EphA2.

from Top Health News -- ScienceDaily http://ift.tt/2oustQG

No comments:

Post a Comment

Scientists find a missing link between Epstein-Barr virus and multiple sclerosis

New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found lar...